Skip to main content

Table 2 Patient Characteristics within Clusters

From: Tailoring integrated care services for high-risk patients with multiple chronic conditions: a risk stratification approach using cluster analysis

 

Total population n = 885

Cluster 1

n = 400

Cluster 2

n = 336

Cluster 3

n = 149

ANOVA/Kruskal-Wallis/χ2 test

1-year mortality risk score (%)

32.15 ± 18.04%

16.95 ± 6.45%

36.64 ± 6.67%

62.84 ± 10.68%

KW < 0.001a

Age (mean ± s.d.)

83.33 ± 8.37

81.16 ± 8.51

84.32 ± 8.05

86.89 ± 6.97

KW < 0.001a

Sex (% Males)

56%

62%

55%

44%

χ2 < 0.001c

Informal Caregiver (%)

91%

88%

94%

93%

χ2: 0.011d

GMA score (mean ± s.d.)

22.81 ± 6.82

22.47 ± 6.39

23.04 ± 7.06

23.24 ± 7.33

AN: 0.379

Barthel scale (mean ± s.d.)

59.95 ± 29.45

82.03 ± 18.16

51.64 ± 17.24

19.40 ± 22.15

KW < 0.001a

Albumin/creatinine index (mean ± s.d.)

1.49 ± 0.67

1.49 ± 0.66

1.51 ± 0.70

1.46 ± 0.66

KW: 0.792

≤30 mg/g: Normal (n, %)

540 (61%)

242 (61%)

203 (60.42%)

95 (64%)

 

30–300 mg/g: Moderate (n, %)

254 (29%)

120 (30%)

94 (28%)

40 (27%)

 

≥300 mg/g: High (n, %)

91 (10%)

38 (9%)

39 (12%)

14 (9%)

 

Creatinine (mg/dL) (mean ± s.d.)

1.52 ± 0.78

1.40 ± 0.59

1.57 ± 0.75

1.72 ± 1.16

KW: 0.002b

Serum albumin (g/dL) (mean ± s.d.)

3.80 ± 0.43

3.90 ± 0.37

3.76 ± 0.41

3.59 ± 0.50

KW < 0.001a

Pressure skin ulcers (%)

28%

21%

26%

55%

χ2 < 0.001c

Number of prescriptions (mean ± s.d.)

8.08 ± 3.55

7.82 ± 3.48

8.47 ± 3.75

7.95 ± 3.20

AN: 0.038d

Intake of opioids (%)

15%

17%

12%

13%

χ2: 0.168

Intake of psycholectics (%)

8%

5%

9%

16%

χ2 < 0.001c

Global severity (mean ± s.d.)

2.87 ± 0.45

2.63 ± 0.50

2.99 ± 0.09

3.22 ± 0.41

KW < 0.001a

Mild (n, %)

4 (< 1%)

4 (1%)

 

Moderate (n, %)

144 (16%)

141 (35%)

3 (1%)

 

Severe (n, %)

704 (80%)

25 (64%)

333 (99%)

116 (78%)

 

Very severe (n, %)

33 (4%)

  

33 (22%)

 

Clinical severity (mean ± s.d.)

3.30 ± 0.68

3.09 ± 0.75

3.43 ± 0.59

3.58 ± 0.55

KW < 0.001a

Mild (n, %)

2 (< 1%)

2 (1%)

 

Moderate (n, %)

110 (12%)

89 (22%)

17 (5%)

4 (3%)

 

Severe (n, %)

393 (44%)

180 (45%)

158 (47%)

55 (37%)

 

Very severe (n, %)

380 (43%)

129 (32%)

161 (48%)

90 (60%)

 

Nursing needs (mean ± s.d.)

2.65 ± 0.88

2.23 ± 0.80

2.82 ± 0.77

3.41 ± 0.66

KW < 0.001a

Mild (n, %)

76 (9%)

66 (16%)

10 (3%)

 

Moderate (n, %)

323 (36%)

204 (51%)

105 (31%)

14 (10%)

 

Severe (n, %)

318 (36%)

103 (26%)

155 (46%)

60 (40%)

 

Very severe (n, %)

168 (19%)

27 (7%)

66 (20%)

75 (50%)

 

Social needs (mean ± s.d.)

1.77 ± 0.70

1.71 ± 0.68

1.82 ± 0.71

1.84 ± 0.73

KW: 0.095

Mild (n, %)

327 (37%)

162 (40%)

116 (35%)

49 (33%)

 

Moderate (n, %)

451 (51%)

199 (50%)

173 (51%)

79 (53%)

 

Severe (n, %)

90 (10%)

33 (8%)

40 (12%)

17 (11%)

 

Very severe (n, %)

17 (2%)

6 (2%)

7 (2%)

4 (3%)

 
  1. KW Kruskal-Wallis test, AN ANOVA, χ2 Chi-squared test
  2. Missing values that were imputed for analysis (% missing): creatinine (0.23%), albumin/creatinine index (2.15%) clinical severity (3.62%), nursing needs (9.38%), global severity (10.96%), Barthel scale (14.24%), serum albumin (15.71%), social needs (43.62%)
  3. aAll clusters are significantly different from each other
  4. bCluster 1 is significantly different to the remaining clusters
  5. cCluster 3 is significantly different to the remaining clusters
  6. dClusters 1 and 2 are significantly different, but there were no other differences in the remaining pairwise post hoc tests